Prognostic utility of serial


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 17 10 2019
medline: 24 12 2019
entrez: 17 10 2019
Statut: ppublish

Résumé

This study explored the value of serial 18-fludeoxyglucose-positron emission tomography ( We prospectively studied 46 patients with LARC who underwent NCRT and surgery. The median follow-up time was 24 months. A reduction in PET parameters showed statistically significant differences for patients with recurrence compared to those without; percentage changes in MTV between PET1 and PET3 (cut-off: 87%, Serial This paper will add to the literature in risk-stratifying patients with LARC based on prognosis, using

Identifiants

pubmed: 31617737
doi: 10.1259/bjr.20190455
pmc: PMC6948083
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20190455

Références

Radiother Oncol. 2014 Nov;113(2):158-65
pubmed: 25483833
Br J Surg. 1997 Oct;84(10):1445-8
pubmed: 9361610
Cancers (Basel). 2014 Sep 29;6(4):1821-89
pubmed: 25268160
Clin Nucl Med. 2014 Jun;39(6):528-30
pubmed: 24806605
AJR Am J Roentgenol. 2015 Jun;204(6):1261-8
pubmed: 26001237
Radiology. 2004 Aug;232(2):335-46
pubmed: 15286305
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
Clin Nucl Med. 2015 Dec;40(12):930-5
pubmed: 26204222
Lancet Gastroenterol Hepatol. 2017 Jul;2(7):501-513
pubmed: 28479372
J Am Coll Surg. 2004 Jul;199(1):1-7
pubmed: 15217621
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
Clin Cancer Res. 2009 Sep 15;15(18):5861-8
pubmed: 19737951
Clin Positron Imaging. 1999 May;2(3):159-171
pubmed: 14516540
Radiother Oncol. 2016 Aug;120(2):195-201
pubmed: 27528121
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Dis Colon Rectum. 2018 Mar;61(3):320-327
pubmed: 29360680
Ann Nucl Med. 2001 Dec;15(6):471-86
pubmed: 11831394
Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8
pubmed: 15383798
Clin Nucl Med. 2016 May;41(5):371-5
pubmed: 26914561
Neoplasia. 2001 May-Jun;3(3):189-95
pubmed: 11494112
Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40
pubmed: 28881920

Auteurs

Sumal Fernando (S)

University of New South Wales, Sydney, Australia.

Michael Lin (M)

University of New South Wales, Sydney, Australia.
Western Sydney University, Sydney, Australia.
Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, Australia.

Trang Thanh Pham (TT)

University of New South Wales, Sydney, Australia.
Western Sydney University, Sydney, Australia.
Department of Radiation Oncology, Liverpool Hospital, Sydney, Australia.
Ingham Institute for Applied Medical Research, Sydney, Australia.

Shanley Chong (S)

University of New South Wales, Sydney, Australia.
Population Health Intelligence, Healthy People and Places Unit, South Western Sydney Local Health District, Sydney, Australia.

Emilia Ip (E)

Ingham Institute for Applied Medical Research, Sydney, Australia.
Department of Medical Oncology, Liverpool Hospital, Sydney, Australia.

Karen Wong (K)

University of New South Wales, Sydney, Australia.
Department of Radiation Oncology, Liverpool Hospital, Sydney, Australia.
Ingham Institute for Applied Medical Research, Sydney, Australia.

Wei Chua (W)

Ingham Institute for Applied Medical Research, Sydney, Australia.
Department of Medical Oncology, Liverpool Hospital, Sydney, Australia.

Weng Ng (W)

University of New South Wales, Sydney, Australia.
Ingham Institute for Applied Medical Research, Sydney, Australia.
Department of Medical Oncology, Liverpool Hospital, Sydney, Australia.

Peter Lin (P)

University of New South Wales, Sydney, Australia.
Western Sydney University, Sydney, Australia.
Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, Australia.

Stephanie Lim (S)

University of New South Wales, Sydney, Australia.
Ingham Institute for Applied Medical Research, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH